Sign Up Now to Download a Free Research Report on

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Galectin Therapeutics Inc.

Galectin Therapeutics is focused on the development of new therapies for fibrotic disease and cancer. Shares of the company surged nearly 20 percent Monday after reporting it has received a U.S. patent for a second drug class to treat chronic liver disease with fibrosis and cirrhosis.

Going forward ... (see research report)



RESEARCH REPORT ON Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on